BMS-986490
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986490, covering 2025-12-15 to 2025-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors [Phase 1, Phase 2]